Sidley Resource
Inflation Reduction Act
Drug Pricing Resource Center
Recommended Insights
-
シドリー最新情報Medicare Part D’s New Cost-Smoothing Program: Key Insights and ImpactsSeptember 17, 2024 Healthcare Update
-
シドリー最新情報Inflation Reduction Act: CMS Releases New “Medicare Drug Price Negotiation Program” Guidance as Industry Lawsuits MountJuly 14, 2023 Global Life Sciences Update
-
ブログImpact Of Inflation Reduction Act On Drug Development For U.S. MarketMay 23, 2023 GoodLifeSci
-
シドリー最新情報HHS Faces IRA Implementation Risk Without Notice and CommentApril 3, 2023 Global Life Sciences Update
-
シドリー最新情報Inflation Reduction Act: CMS Solicits Comments on Price Negotiation Program Guidance, Makes Part B Coinsurance AnnouncementsMarch 20, 2023 Global Life Sciences Update
-
シドリー最新情報U.S. Inflation Reduction Act Implementation: Public Opportunities to Comment on New Medicare Inflation Rebates ProgramFebruary 17, 2023 Global Life Sciences Update
-
シドリー最新情報Inflation Reduction Act Implementation: Serious Hurdles to Accurately Calculating Medicare Part B Inflation RebatesFebruary 14, 2023 Global Life Sciences Update
-
シドリー最新情報Inflation Reduction Act Implementation: Public Input Opportunities Related to U.S. Medicare Drug Price Negotiation ProgramFebruary 3, 2023 Global Life Sciences Update
-
シドリー最新情報Unprecedented Changes to Medicare Programs Leave Many Questions Unanswered for Pharmaceutical ManufacturersAugust 29, 2022 Global Life Sciences Update
Contacts
最新情報はこちらから